References of "Plenevaux, Alain"
     in
Bookmark and Share    
Full Text
See detailSynthesis of an universal linker to label oligonucleotides via Click Chemistry
Flagothier, Jessica ULg; Mercier, Frederic; Kaisin, Geoffroy ULg et al

Poster (2009, January 21)

For more than 3 decades, oligonucleotides have been used for therapies, imaging and diagnostics. They are known to hybridize specifically with RNA of a complementary sequence on tissue sections and more ... [more ▼]

For more than 3 decades, oligonucleotides have been used for therapies, imaging and diagnostics. They are known to hybridize specifically with RNA of a complementary sequence on tissue sections and more recently to block the expression of target mRNA when administered in vivo (1). Positron emission Tomography (PET) is a sensitive and non invasive imaging technique, and is the most advanced technology currently available for studying in vivo molecular interactions and therapeutic agents. It is a method of choice to assess the pharmacokinetics of new therapeutics agents such as modified oligonucleotides. Among positron-emitting nuclides, fluorine-18 (t1/2 = 109.8 min) appears to be the best candidate due to its favourable physical and nuclear properties. Several of the methods described in the literature to label oligonucleotides present a number of disadvantages (time of synthesis, low overall radiolabelling yield, non-universal). Due to the speed, selectiveness and the relatively mild experimentals conditions, “Click” chemistry seems a powerful technique. The most explored Click reaction is Huisgen 1,3 dipolar cycloaddition. In our case, this reaction occurs between an alkyne group presents on the oligonucleotide and an azide group on the 18F labelled prosthetic group. The originality of our strategy is the use of a universal linker diverted from the trans-4-hydroxy-proline directly connected to the oligonucleotide. This linker mimics a sugar of the oligonucleotide sequence and should improve their resistance to exonucleases. Synthesis of this compound will be presented. [less ▲]

Detailed reference viewed: 37 (3 ULg)
Full Text
Peer Reviewed
See detailMetabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Aerts, Joël ULg; Plenevaux, Alain ULg; Lemaire, Christian ULg et al

in BMC Medical Physics (2008), 8

Background: Several fluorine-18 labelled fluoroamino acids have been evaluated as tracers for the quantitative assessment of cerebral protein synthesis in vivo by positron emission tomography (PET). Among ... [more ▼]

Background: Several fluorine-18 labelled fluoroamino acids have been evaluated as tracers for the quantitative assessment of cerebral protein synthesis in vivo by positron emission tomography (PET). Among these, 2-[18F]fluoro-L-tyrosine (2-[18F]Tyr) has been studied in mice at a low specific activity. Its incorporation into proteins is fast and metabolism via other pathways is limited. The present in vivo study was carried out in normal awake rats using no-carrier-added 2-[18F]Tyr. Under normal physiological conditions, we have studied the incorporation into proteins and the metabolism of the tracer in different brain areas. Methods: No-carrier-added 2-[18F]Tyr was administered to awake rats equipped with chronic arterial and venous catheters. The time course of the plasma activity was studied by arterial blood sampling. The biodistribution of the activity in the main organs was studied at the end of the experiment. The distribution of radioactive species in plasma and brain regions was studied by acidic precipitation of the proteins and HPLC analysis of the supernatant. Results: The absolute uptake of radioactivity in brain regions was homogenous. In awake rats, nocarrier-added 2-[18F]Tyr exhibits a fast and almost quantitative incorporation into the proteins fractions of cerebellum and cortex. In striatum, this incorporation into proteins and the unchanged fraction of the tracer detected by HPLC could be lower than in other brain regions. Conclusion: This study confirms the potential of 2-[18F]fluoro-L-tyrosine as a tracer for the assessment of the rate of protein synthesis by positron emission tomography. The observed metabolism suggests a need for a correction for the appearance of metabolites, at least in plasma. [less ▲]

Detailed reference viewed: 28 (14 ULg)
Peer Reviewed
See detailImage Quality, Accuracy of Attenuation and Scatter Corrections of the microPET Focus 120 Using the NEMA NU4-2008 Phantom
Bahri, Mohamed Ali ULg; Plenevaux, Alain ULg; Seret, Alain ULg

Poster (2008, October)

This work aimed at evaluating the image quality and the accuracy of attenuation and scatter corrections methodologies provided with the microPET Focus 120 scanner. The protocol used here is described in ... [more ▼]

This work aimed at evaluating the image quality and the accuracy of attenuation and scatter corrections methodologies provided with the microPET Focus 120 scanner. The protocol used here is described in the forthcoming NEMA NU4-2008 document. This study included 1 h transmission experiments, with two sources (68Ge and 57Co, both one half-live old), in coincidence mode (Ge) with and without windowing, and singles mode (Ge and Co). Transmission data with Co were also collected for shorter acquisition times (515/1030/2060 s). Transmission with scatter correction, and emission with attenuation with or without scatter correction, slices were reconstructed using 2D-FBP (ramp filter). The uniformity, the recovery coefficients (RC) and the accuracy of corrections were evaluated as described in the NEMA document. We also determined the attenuation coefficient (AC) for water using the methodology applied to measure the mean pixel value for the emission slices of the uniform part of the phantom. The Co single mode measurements provided a mean AC for water closer to the theoretical value than the Ge measurements either in single or in coincidence mode even for the shortest acquisition time. Moreover, the lowest coefficients of variation per pixel of the uniform slices were measured for attenuation corrected data based on Co measurements. Also, spill-over ratio for non-emitting air and water compartments reflected a higher capability of this attenuation correction method for scatter correction. The RC measured on emission image corrected only for attenuation did not show any significant difference linked to the transmission measured methods. However, higher RC values were noted for Ge coincidence with windowing when emission data were corrected for both attenuation and scatter. Hence, Co singles transmission seems to be the most suitable method for attenuation correction on the microPET Focus 120 scanner. [less ▲]

Detailed reference viewed: 84 (19 ULg)
Full Text
Peer Reviewed
See detail18F LABELING OF BIOMOLECULES USING CLICK CHEMISTRY FOR PET APPLICATIONS : SYNTHETIC DEVELOPMENTS
Thonon, David ULg; Flagothier, Jessica ULg; Paris, Jérôme ULg et al

in Drugs of the Future (2008, August), 33(A), 235

Detailed reference viewed: 79 (15 ULg)
Full Text
Peer Reviewed
See detailThe Effect of Clonidine Infusion on Distribution of Regional Cerebral Blood Flow in Volunteers
Bonhomme, Vincent ULg; Maquet, Pierre ULg; Phillips, Christophe ULg et al

in Anesthesia and Analgesia (2008), 106(3), 899-909

BACKGROUND: Through their action on the locus coeruleus, alpha2-adrenoceptor agonists induce rapidly reversible sedation while partially preserving cognitive brain functions. Our goal in this ... [more ▼]

BACKGROUND: Through their action on the locus coeruleus, alpha2-adrenoceptor agonists induce rapidly reversible sedation while partially preserving cognitive brain functions. Our goal in this observational study was to map brain regions whose activity is modified by clonidine infusion so as to better understand its loci of action, especially in relation to sedation. METHODS: Six ASA I-II right-handed volunteers were recruited. Electroencephalogram (EEG) was monitored continuously. After a baseline H2(15)O activation scan, clonidine infusion was started at a rate ranging from 6 to 10 microg x kg(-1) x h(-1). A sequence of 11 similar scans was then performed at 8 min intervals. Plasma clonidine concentration was measured. Using statistical parametric mapping, we sought linear correlations between normalized regional cerebral blood flow (rCBF), an indicator of regional brain activity, and plasma clonidine concentration or spindle EEG activity. RESULTS: Clonidine induced clinical sedation and EEG patterns (spindles) comparable to early stage nonrapid eye movement sleep. A significant negative linear correlation between clonidine concentration and rCBF or spindle activity was observed in the thalamus, prefrontal, orbital and parietal association cortex, posterior cingulate cortex, and precuneus. CONCLUSIONS: The EEG patterns and decreases in rCBF of specific brain regions observed during clonidine-induced sedation are similar to those of early stage nonrapid eye movement sleep. Patterns of deactivated brain regions are also comparable to those observed during general anesthesia or vegetative state, reinforcing the hypothesis that alterations in the activity of a common network occur during these modified conscious states. [less ▲]

Detailed reference viewed: 94 (14 ULg)
Peer Reviewed
See detailAttenuation and scatter correction accuracy of the microPET Focus 120 assessed with the NEMA NU-4 2008 phantom.
Bahri, Mohamed Ali ULg; Plenevaux, Alain ULg; Seret, Alain ULg

in European Journal of Nuclear Medicine and Molecular Imaging (2008), 35(S2), 193

Detailed reference viewed: 78 (15 ULg)
Full Text
Peer Reviewed
See detailCyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
Lacan, Goran; Plenevaux, Alain ULg; Rubins, Daniel J. et al

in European Journal of Nuclear Medicine and Molecular Imaging (2008), 35(12), 2256-66

PURPOSE: Pretreatment with cyclosporine, a P-glycoprotein (P-gp) modulator increases brain uptake of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethylpiperaz ine ([(18)F]MPPF) for ... [more ▼]

PURPOSE: Pretreatment with cyclosporine, a P-glycoprotein (P-gp) modulator increases brain uptake of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethylpiperaz ine ([(18)F]MPPF) for binding to hydroxytryptamine(1A) (5-HT(1A)) receptors. Those increases were quantified in rat brain with in vivo microPET and ex vivo tissue studies. MATERIALS AND METHODS: Each Sprague-Dawley rat (n = 4) received a baseline [(18)F]MPPF microPET scan followed by second scan 2-3 weeks later that included cyclosporine pretreatment (50 mg/kg, i.p.). Maximum a posteriori reconstructed images and volumetric ROIs were used to generate dynamic radioactivity concentration measurements for hippocampus, striatum, and cerebellum, with simplified reference tissue method (SRTM) analysis. Western blots were used to semiquantify P-gp regional distribution in brain. RESULTS: MicroPET studies showed that hippocampus uptake of [(18)F]MPPF was increased after cyclosporine; ex vivo studies showed similar increases in hippocampus and frontal cortex at 30 min, and for heart and kidney at 2.5 and 5 min, without concomitant increases in [(18)F]MPPF plasma concentration. P-gp content in cerebellum was twofold higher than in hippocampus or frontal cortex. CONCLUSIONS: These studies confirm and extend prior ex vivo results (J. Passchier, et al., Eur J Pharmacol, 2000) that showed [(18)F]MPPF as a substrate for P-gp. Our microPET results showed that P-gp modulation of [(18)F]MPPF binding to 5-HT(1A) receptors can be imaged in rat hippocampus. The heterogeneous brain distribution of P-gp appeared to invalidate the use of cerebellum as a nonspecific reference region for SRTM modeling. Regional quantitation of P-gp may be necessary for accurate PET assessment of 5-HT(1A) receptor density when based on tracer uptake sensitive to P-gp modulation. [less ▲]

Detailed reference viewed: 71 (6 ULg)
Full Text
Peer Reviewed
See detailCharacterization of 4-(2-hydroxyphenyl)-1-[2 '-[N-(2 ''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist
Defraiteur, Caroline ULg; Plenevaux, Alain ULg; Scuvée-Moreau, Jacqueline ULg et al

in British Journal of Pharmacology (2007), 152(6), 952-958

Background and purpose: The identification of potent and selective radioligands for the mapping of 5-HT receptors is interesting both for clinical and experimental research. The aim of this study was to ... [more ▼]

Background and purpose: The identification of potent and selective radioligands for the mapping of 5-HT receptors is interesting both for clinical and experimental research. The aim of this study was to compare the potency of a new putative 5-HT1A receptor antagonist, p-DMPPF, (4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]-ethyl] piperazine) with that of the well-known 5-HT1A antagonists, WAY-100635(N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide) and its fluorobenzoyl analogue, p-MPPF (4-(2-methoxyphenyl)-1-[2'-[N-(2''-pyridinyl)p-fluorobenzamido] ethyl] piperazine). Experimental approach: Single cell extracellular recordings of dorsal raphe (DR) neurones were performed in rat brain slices. The potency of each compound at antagonizing the effect of the 5-HT1A agonist, 8-OH-DPAT [8-hydroxy-2-(di-npropylamino)tetraline], was quantified using the Schild equation. The pharmacological profile of p-DMPPF was defined using competition binding assays. Key results: Consistently with a 5-HT1A receptor antagonist profile, incubation of slices with an equimolar (10 nM) concentration of each compound markedly reduced the inhibitory effect of 8-OH-DPAT on the firing rate of DR neurones, causing a significant rightward shift in its concentration-response curve. The rank order of potency of the antagonists was WAY-100635 > p-DMPPF >= p-MPPF. The sensitivity of DR neurones to the inhibitory effect of 8-OH-DPAT was found to be heterogeneous. The binding experiments demonstrated that p-DMPPF is highly selective for 5-HT1A receptors, with a K-i value of 7 nM on these receptors. Conclusions and implications: The potency of the new compound, p-DMPPF, as a 5-HT1A antagonist is similar to that of p-MPPF in our electrophysiological assay. Its selectivity towards 5-HT1A receptors makes it a good candidate for clinical development. [less ▲]

Detailed reference viewed: 53 (26 ULg)
Full Text
Peer Reviewed
See detailThe challenge of disentangling reportability and phenomenal consciousness in post-comatose states
Vanhaudenhuyse, Audrey ULg; Bruno, Marie-Aurélie ULg; Brédart, Serge ULg et al

in Behavioral And Brain Sciences (2007), 30(5-6), 529-530

Determining whether or not noncommunicative patients are phenomenally conscious is a major clinical and ethical challenge. Clinical assessment is usually limited to the observation of these patients ... [more ▼]

Determining whether or not noncommunicative patients are phenomenally conscious is a major clinical and ethical challenge. Clinical assessment is usually limited to the observation of these patients' motor responses. Recent neuroimaging technology and brain computer interfaces help clinicians to assess whether patients are conscious or not, and to avoid diagnostic errors. [less ▲]

Detailed reference viewed: 21 (3 ULg)
Full Text
Peer Reviewed
See detailRadiochemical synthesis and tissue distribution of p-[F-18]DMPPF, a new 5-HT1A ligand for PET, in rats
Defraiteur, Caroline; Lemaire, Christian ULg; Luxen, André ULg et al

in Nuclear Medicine & Biology (2006), 33(5), 667-675

Several studies have demonstrated the potential of p-[F-18]MPPF as a radiophanilaceutical to study the 5-HT1A receptor family in animals and humans. A structural modification leading to a higher ... [more ▼]

Several studies have demonstrated the potential of p-[F-18]MPPF as a radiophanilaceutical to study the 5-HT1A receptor family in animals and humans. A structural modification leading to a higher radioactive signal at an equipotent dose would greatly enhance this potential. With this goal, the desmethylated 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-fluorobenzamidolethyl]-piperazine (p-MPPF), identified as p-DMPPF, was synthesized, labeled with fluorine-18 and evaluated through ex vivo tissue distribution in rats. The new compounds p-DMPPF, p-DMPPNO2, MEM-p-MPPF and MEM-p-MPPNO2 were isolated and fully identified (H-1 and C-13 NMR, LC-MS). The final compound, p-[F-18]DMPPF, was obtained ready for injection, with an overall radiochemical yield of 10% (EOB corrected) within 90 min and a specific activity of 62 GBq/mu mol. Tissue distributions showed that the carbon-fluorine bond was stable in vivo and that this compound could cross the blood-brain barrier. For kidney, lung, heart, spleen, bone, testicle, liver and muscle, the percentage of injected dose per gram of tissue obtained with p-[F-18]DMPPF was of the same order of magnitude as that of p-[F-18]MPPF. The amount of radioactivity reaching the brain was much higher (approximately fivefold at 60 min) for p-[F-18]DMPPF compared with p-[F-18]MPPF, which was taken as reference. The distribution and specificity were in total agreement with the known localization of 5-HT1A receptors in rats. The radioactivity increase was more important for specific tissues (hippocampus and frontal cortex) than for cerebellum or striatum, leading to better contrast (hippocampus/cerebellum=5.8 at 60 min). The levels of metabolites found in plasma showed that p-[F-18]DMPPF appears to be less metabolized than p-[F-18]MPPF. p-[F-18]DMPPF deserves further evaluation as a radiopharmaceutical candidate. (c) 2006 Elsevier Inc. All rights reserved. [less ▲]

Detailed reference viewed: 120 (6 ULg)
Full Text
Peer Reviewed
See detailDEVELOPPEMENT D'INHIBITEURS SELECTIFS DE LA TRYPTOPHANE HYDROXYLASE
Giacomelli, Fabrice ULg; Luxen, André ULg; Lemaire, Christian ULg et al

Conference (2006, February 03)

Comprendre la façon dont le cerveau travaille et en particulier le mode de communication de ses cellules est un rêve que beaucoup de chercheurs caressent. A l’heure actuelle, une des rares certitudes à ... [more ▼]

Comprendre la façon dont le cerveau travaille et en particulier le mode de communication de ses cellules est un rêve que beaucoup de chercheurs caressent. A l’heure actuelle, une des rares certitudes à son sujet est qu’un de ses modes de transmission d’informations utilise des « messagers » chimiques appelés neurotransmetteurs. Parmi ceux-ci, la sérotonine (5-HT) revêt une importance particulière. En effet, la 5-HT est impliquée dans de nombreuses fonctions (apprentissage, locomotion, sommeil,…) et pathologies (dépressions, démences, schizophrénies,…). Dès lors, l'étude in vivo chez l'homme des neurones sérotoninergiques ainsi que la quantification de la vitesse de biosynthèse de la 5-HT sont des domaines d'études fondamentaux pour lesquels la tomographie à émission de positons (TEP) constitue un outil de choix. Pour mener à bien ces différentes expérimentations, deux stratégies sont envisageables : - L’emploi d'un traceur capable de suivre la chaîne métabolique du tryptophane conduisant à la 5-HT tout en évitant les autres voies métaboliques. - L’utilisation d'un inhibiteur de la TrpOH (enzyme limitant du processus). Dans le cadre de cette présentation, nous nous intéresserons plus particulièrement à la deuxième stratégie. [less ▲]

Detailed reference viewed: 27 (2 ULg)
Peer Reviewed
See detailSynthesis of protected meso-diaminopimelic acid.
Teller, N.; Lemaire, Christian ULg; Plenevaux, Alain ULg et al

Poster (2005, October 10)

Detailed reference viewed: 10 (1 ULg)
Peer Reviewed
See detailSynthesis of anhydro-muranic acid derivatives as substrates for MurNAc amidase.
Mercier, F.; Lemaire, Christian ULg; Plenevaux, Alain ULg et al

Poster (2005, October 10)

Detailed reference viewed: 12 (5 ULg)